IDIQ for the purchase of consumables (multi-well plates) for use in Axion Biosystems Multielectrode Array systems
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Food and Drug Administration (FDA), specifically the Center for Drug Evaluation and Research (CDER), Division of Applied Regulatory Science (DARS), has issued a Sources Sought Notice (SSN) for an Indefinite Delivery, Indefinite Quantity (IDIQ) contract. This market survey aims to identify small business sources capable of providing multi-well plates (12, 48, and 96-well) with a minimum of 700 electrodes per plate for use in Axion Biosystems Multielectrode Array (MEA) systems. These consumables are crucial for microphysiological studies supporting regulatory science research in drug safety and efficacy. Capability statements are due by June 3, 2026.
Scope of Requirement
The FDA requires newly manufactured multi-well plates that offer specific functionalities for real-time electrophysiological activity monitoring. Key features include real-time well-by-well review of raw signals, plate-wide feedback, high signal quality with adjustable filters, temperature and electrical stimulation control, and automatic identification of cardiac T-wave and neural network burst capabilities. The plates must support various measurement capabilities such as field potential duration, beat period, conduction velocity, and mean firing rate, and have pacing capabilities. Specific quantities for various plate types are listed, though some are currently unknown.
Contract Details
- Opportunity Type: Sources Sought Notice (SSN)
- Contract Vehicle: Indefinite Delivery, Indefinite Quantity (IDIQ)
- Period of Performance: A base year (July 31, 2026 – July 30, 2027) with four (4) option years, extending through July 30, 2031.
- Delivery: Within 30 days after receipt of an order.
- NAICS Code: 334516 – Analytical Laboratory Instrument Manufacturing (Small Business Size Standard: 1,000 employees).
Eligibility & Submission
- Target Audience: Primarily small businesses capable of supplying a U.S. product/service. Other than small business concerns are also encouraged to submit.
- Response Type: Capability statements only; this is not a request for proposals or quotes.
- Submission Deadline: June 3, 2026, at 3:00 PM Central Time.
- Submission Method: Email only to Suzanne Martella (suzanne.martella@fda.hhs.gov).
- Required Information: Business name/bio, Unique Entity ID (SAM), business address, business size status, contact information, past performance (last 3 years), descriptive literature, technical information, GSA Schedule/BIC contract info (if applicable), and optional informational pricing.
Important Notes
This is a market survey for planning purposes only. No contract will be awarded from this announcement, and no reimbursement will be made for response costs. Responses must demonstrate capability, not merely affirm it. Proprietary or sensitive information should not be included.